Pervasip Corp (PVSP) 0.0008 $PVSP Pervasip To Merge With

New Post Public Reply Private Reply Replies (0) Message Board

Jul 15, 2015 at 6:06 PM

Pervasip Corp (PVSP) 0.0008 $PVSP

Pervasip To Merge With Plaid Canary Corporation
PR Newswire - Wed Jul 08, 8:00AM CDT
Pervasip Corp. (USOTC: PVSP) ("Pervasip" or the "Company"

announced today its execution of an agreement to merge with and into the Company's wholly-owned subsidiary, Plaid Canary Corporation ("Canary"

, a special purpose consolidation company focused on acquiring, developing and supporting companies and technologies in emerging agricultural markets.

Pervasip Acquires Plaid Canary Corporation
PR Newswire - Thu Jul 02, 11:24AM CDT
Pervasip Corp. (USOTC: PVSP) ("Pervasip" or the "Company"

announced today its execution and closing of agreements to acquire 100% of the issued and outstanding equity of Plaid Canary Corporation ("Canary"

, a special purpose consolidation company focused on acquiring, developing and supporting companies and technologies in emerging agricultural markets.

Pervasip Releases Shareholder Letter
PR Newswire - Mon Jun 29, 1:15PM CDT
Paul Riss, chief executive officer of Pervasip Corp. (USOTC: PVSP) ("Pervasip" or the "Company"

, issued the following letter today to the shareholders of Pervasip:

Pervasip Enters Into Agreement to Absorb Dilution From Debt Conversions
PR Newswire - Fri May 15, 2:15PM CDT
Pervasip Corp. (USOTC: PVSP) ("Pervasip" or the "Company"

announced today an agreement with Flux Carbon Corporation ("FCC"

in which FCC agrees to absorb the impact of common stock issued by the Company to its secured debt holders who choose to convert their debt into shares of common stock.

Pervasip Provides Acquisition Update
PR Newswire - Wed May 06, 8:20AM CDT
Pervasip Corp. (USOTC: PVSP) ("Pervasip" or the "Company"

provided an update on its ongoing acquisition efforts.

Pervasip Provides Acquisition and Restructuring Update
PR Newswire - Thu Apr 02, 12:34PM CDT
Pervasip Corp. (USOTC: PVSP) ("Pervasip" or the "Company"

provided an update on its previously announced and ongoing restructuring and acquisition efforts.

Penny Stocks Reports for Mind Solutions, Interactive Health Network, Payment Data Systems, MEDIJANE, CANNABIZ MOBILE, and Pervasip
PR Newswire - Wed Apr 01, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Mind Solutions (OTCMKTS:VOIS), Interactive Health Network (OTCMKTS:IGRW), Payment Data Systems (OTCMKTS

YDS), MEDIJANE (OTCMKTS:MJMD), CANNABIZ MOBILE (OTCMKTS:LGBI), and Pervasip (OTCMKTS

VSP).

Pervasip acquires 90% of Canalytix
M2 - Fri Mar 27, 8:23AM CDT
Pervasip Corp. (USOTC: PVSP) said it has closed on an agreement to acquire 90 percent of the issued and outstanding equity of Canalytix LLC, an energy and resource solutions provider based in Denver, Colorado.

Pervasip Completes Acquisition
PR Newswire - Thu Mar 26, 10:00AM CDT
Pervasip Corp. (USOTC: PVSP) ("Pervasip" or the "Company"

announced its execution and closing of an agreement to acquire 90% of the issued and outstanding equity of Canalytix LLC, an energy and resource solutions provider based in Denver, Colorado.

Pervasip Announces Acquisition of Indoor Agricultural Business
ACCESSWIRE - Thu Feb 12, 10:25AM CST
WHITE PLAINS, NY / ACCESSWIRE / February 12, 2015 / InvestorsHub NewsWire - Pervasip Corp. (USOTC

VSP) ("Pervasip" or the "Company"

announced that it has agreed to acquire 100% of the issued and outstanding equity of Canalytix LLC.

Pervasip Executes Debt Modification Agreements to Reduce Debt By $1.4 Million
ACCESSWIRE - Tue Jan 27, 8:01AM CST
WHITE PLAINS, NY / ACCESSWIRE / January 27, 2015 / Pervasip Corp. (USOTC: PVSP) ("Pervasip" or the "Company"

today announced its execution of agreements to eliminate an additional $1.4 million in debt.

Pervasip Provides Update on Restructuring Plan
ACCESSWIRE - Fri Jan 23, 8:35AM CST
WHITE PLAINS, NY / ACCESSWIRE / January 23, 2015 / Pervasip Corp. (OTCQB: PVSP) ("Pervasip" or the "Company"

today provided an update of its ongoing restructuring efforts.

Pervasip Announces Agreement to Reduce Debt by $1.9 million
ACCESSWIRE - Wed Jan 14, 2:30PM CST
WHITE PLAINS, NY / ACCESSWIRE / January 14, 2015 / Pervasip Corp. (OTCQB: PVSP) ("Pervasip" or the "Company"

announced today that it executed an agreement with Pension Benefit Guarantee Corporation (the "PBGC"

, pursuant to which PBGC agreed to accept $100,000 in full satisfaction of $2.0 million in amounts that had been due from Pervasip.

Pervasip Announces Debt Restructuring Plan
ACCESSWIRE - Tue Jan 13, 11:05AM CST
WHITE PLAINS, NY / ACCESSWIRE / January 13, 2015 / Pervasip Corp. (USOTC

VSP) ("Pervasip" or the "Company"

announced that it is in conversations with several of its creditors and aims to release details of a debt restructuring plan that will eliminate a minimum of $1.5 million in debt payable from its balance sheet.

Valuesetters Growing Business Along Same Principles As Netflix, Tangoe, And Skype
ACCESSWIRE - Mon Oct 20, 7:33AM CDT
Salt Lake City, UT / ACCESSWIRE / October 20, 2014 / With over a million apps available to most consumers with a portable, digital device, as well as the launch of several new tablets and smartphones near the end of 2014, the market for digital property has never been bigger or brighter. Apps and mobile gaming are exploding as mobile gaming helped the digital games market reach $14 billion in 2013, a number expected to rise each year for the foreseeable future. Valuesetters (VSTR) aims to capitalize on multiple facets of the digital boom, and brings to the table the right amount of ingenuity, experience, and innovation to bring digital media to the next level, all while building a wildly successful company.
NFLX: 98.13 (-2.24), TNGO: 12.58 (+0.05), FB: 89.76 (+0.08), MSFT: 45.76 (+0.14)

Pervasip restructures to go virtual
M2 - Mon Oct 06, 7:39AM CDT
Pervasip Corp. (OTC: PVSP) said that it entered into an agreement to sell and license back its award-winning VoIP technology platform.

Pervasip Goes Virtual
PR Newswire - Fri Oct 03, 1:00PM CDT
Pervasip Corp. (OTC Pink: PVSP) announced that it entered into an agreement to sell and license back its award-winning VoIP technology platform.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...